- Clinical Characteristics of Psoriasis for Initiation of Biologic Therapy: A Cluster Analysis
-
Kim YH, Kim SI, Park B, Lee ES
- KMID: 2541116
- Ann Dermatol.
- 2023 Apr;35(2):132-139.
- doi: 10.5021/ad.22.148
Background: Psoriasis is a complex and heterogeneous disease that widely affects a patient’s life. Biological therapy is usually prescribed in patients with severe psoriasis that do not respond to conventional... -
- CITED
-
- Close
- SHARE
-
- Close
- Real-World Outcomes of Adalimumab Treatment for Moderate and Severe Psoriasis in Korean Patients (RAPSODI Study)
-
Kim DH, Son SW, Jeong KH, Ahn J, Lee ES, Kim IH, Lee UH, Park HJ, Ko JY, Kim BS, Kim JJ, Rashid J, Kim KJ
- KMID: 2541113
- Ann Dermatol.
- 2023 Apr;35(2):107-115.
- doi: 10.5021/ad.22.041
Background: Psoriasis imposes a significant treatment burden on patients, particularly impacting well-being and quality of life (QoL). The psychosocial impact of psoriasis treatments remains unexplored in most patient populations. Objective: To... -
- CITED
-
- Close
- SHARE
-
- Close
- Comparison of Risk Allele Frequencies of Psoriasis-Associated Single-Nucleotide Polymorphisms in Different Population Groups
-
Lee D, Koo T, Park J, Shin HT
- KMID: 2541096
- Ann Dermatol.
- 2023 Feb;35(1):32-37.
- doi: 10.5021/ad.22.110
Background: The prevalence of psoriasis differs by population, and it appears to be more common among Europeans than in East Asians. Recent genome-wide association studies (GWAS) have identified alleles that... -
- CITED
-
- Close
- SHARE
-
- Close
- Which Areas Are Still Left in Biologics Responsive Korean Patients with Moderate to Severe Plaque Psoriasis
-
Won SH, Shin BS, Bae KN, Son JH, Shin K, Kim HS, Ko HC, Kim MB, Kim BS
- KMID: 2541093
- Ann Dermatol.
- 2023 Feb;35(1):6-10.
- doi: 10.5021/ad.21.274
Background: Psoriasis localized to certain body areas, such as the scalp, nails, palms, soles, intertriginous regions, and genital regions, is reportedly difficult to treat. Objective: To investigate the biologics-resistant areas in... -
- CITED
-
- Close
- SHARE
-
- Close
- BNT162b2 (Pfizer) mRNA Covid-19 Vaccine Induced De Novo Generalized Pustular Psoriasis
-
Kim C, Kim K, Jung KE
- KMID: 2539344
- Korean J Dermatol.
- 2023 Jan;61(1):71-73.
-
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Rebound Phenomenon after Cessation of Cyclosporine for Guselkumab Therapy in Psoriasis
-
Park SH, Jung SY
- KMID: 2538565
- Korean J Dermatol.
- 2022 Dec;60(10):679-682.
Cyclosporine is one of the main therapeutic agents for psoriasis. It is known that psoriasis relapses 2∼3 months after discontinuation of cyclosporine, and exacerbation due to abrupt discontinuation of cyclosporine... -
- CITED
-
- Close
- SHARE
-
- Close
- Effect of Activating Transcription Factor 3 on Inflammatory Response and Differentiation of Keratinocytes
-
Kim K, Kim D, Shin JM, Hong D, Jung KE, Seo YJ, Lee Y, Kim CD
- KMID: 2538560
- Korean J Dermatol.
- 2022 Dec;60(10):640-646.
Background: Pathogenesis of psoriasis is related to dysregulated keratinocyte function and immune responses. Genetic background is one of the most important factors in disease pathogenesis. However, psoriasis-associated genes have not... -
- CITED
-
- Close
- SHARE
-
- Close
- Latent Tuberculosis Infection in Adult Patients with Severe Psoriasis Treated with Biologics at a Single Medical Center
-
Choi KH, Eun DH, Lee JY
- KMID: 2538559
- Korean J Dermatol.
- 2022 Dec;60(10):631-639.
Background: Biologics have been increasingly used in the treatment of severe psoriasis. However, evidence regarding the results of tuberculosis (TB) screening and risk of latent tuberculosis infection (LTBI) during treatment... -
- CITED
-
- Close
- SHARE
-
- Close
- Low-level laser therapy in immune-mediated skin disease: a narrative review
-
Seok J, Koh YG, Kim BJ
- KMID: 2537591
- Med Lasers.
- 2022 Dec;11(4):189-194.
- doi: 10.25289/ML.22.043
Low-level laser therapy (LLLT) is now widely used in dermatology due to the relatively low risk of adverse events. LLLT can modulate mitochondria levels and affect various cell types, such... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Multiple Hyperkeratotic Seborrheic Keratosis in Psoriasis Lesion after Phototherapy
-
Kim JS, Lee JS, Koo DW
- KMID: 2536325
- Korean J Dermatol.
- 2022 Nov;60(9):618-630.
-
- CITED
-
- Close
- SHARE
-
- Close
- Eczematous Vesicular Rruption and Exacerbation of Chronic Spontaneous Urticaria Associated with Secukinumab
-
Choi SM, Lew BL, Sim WY, Kwon SH
- KMID: 2536323
- Korean J Dermatol.
- 2022 Nov;60(9):611-614.
The pathogenesis of chronic spontaneous urticaria (CSU) is complex. Though the involvement of functional autoantibodies and imbalance of T helper (Th) cell subsets have been reported, the exact mechanism remains... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Generalized Granuloma Annulare Development in a Psoriasis Patient Treated with Interleukin-12/23 Blockers
-
Kim J, Jang B, Kim Y, Won SH, Bae KN, Lee J, Shin K, Kim H, Ko H, Kim MB, Kim B
- KMID: 2536322
- Korean J Dermatol.
- 2022 Nov;60(9):606-610.
Granuloma annulare is a relatively common inflammatory skin disease. The etiology is unknown; however, drugs have been considered as one of the predisposing conditions, and a few cases of granuloma... -
- CITED
-
- Close
- SHARE
-
- Close
- Expression of Antimicrobial Peptides in Psoriasiform Mouse Models
-
Kim SE, Lee SE, Kim SC, Kim JH
- KMID: 2536318
- Korean J Dermatol.
- 2022 Nov;60(9):585-592.
Background: Psoriasis is a chronic inflammatory skin disease. Despite the current focus on T cells in the pathogenesis of psoriasis, keratinocytes within the psoriatic epidermis are also abnormal in many... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical Efficacy and Safety of Guselkumab in the Treatment of Moderate-to-Severe Psoriasis in Korea
-
Shin JO, Bae KN, Son JH, Shin K, Kim H, Ko H, Kim MB, Kim B
- KMID: 2536315
- Korean J Dermatol.
- 2022 Nov;60(9):559-565.
Background: Guselkumab, a human immunoglobulin-G1λ monoclonal antibody, selectively blocks the interleukin-23-mediated signaling pathway. It has emerged as a promising treatment option for moderate-to-severe psoriasis. However, no studies have reported real-world... -
- CITED
-
- Close
- SHARE
-
- Close
- Available Alternative Biologics and Disease Groups Influence Biologic Drug Survival in Patients with Psoriasis and Psoriatic Arthritis
-
Oh S, Choi S, Yoon HS
- KMID: 2533604
- Ann Dermatol.
- 2022 Oct;34(5):321-330.
- doi: 10.5021/ad.22.003
Background: Factors other than efficacy and safety could influence the survival of biologics in patients with psoriasis. Little is known about whether different disease groups affect drug survival of biologics... -
- CITED
-
- Close
- SHARE
-
- Close
- Negative Correlation between CD163 Expression and Psoriasis Severity
-
Seo BH, Kim JS, Cha DR, Kim JH, Choi YS, Cha HJ, Suh HS
- KMID: 2534011
- Korean J Dermatol.
- 2022 Sep;60(8):499-504.
Background: Psoriasis is a chronic inflammatory skin disease, wherein macrophages play a key role. An imbalance in transition from the classical activation (M1) to alternative activation (M2) phenotype in macrophages... -
- CITED
-
- Close
- SHARE
-
- Close
- Analysis of the Switching Patterns of Biologics and Their Efficacy after Switching in Moderate-to-Severe Psoriasis Patients
-
Lee SM, Ko BC, Ahn SW, Uh JA, Seol JE, Kim H, Lee SK, Kim MS, Lee UH, Park SH, Jung SY, Park HJ
- KMID: 2532844
- Korean J Dermatol.
- 2022 Aug;60(7):420-428.
Background: Biologics-experienced patients are more likely to show a lower response to biologics than that of biologic-naïve patients. However, no consensus on switching biologics exists. Objective: We aimed to investigate the... -
- CITED
-
- Close
- SHARE
-
- Close
- Alteration of Th1 and Th17 Inflammatory Cytokines in the Skin Lesions after Psoriasis Treatment
-
Park HJ, Chang HJ, Kim TG, Kwon MY, Lim CY, Ju HJ, Lee KH, Park CJ
- KMID: 2532842
- Korean J Dermatol.
- 2022 Aug;60(7):409-413.
Background: Psoriasis is a T cell-mediated disorder. Appropriate treatment of psoriasis can result in a plethora of dynamic changes in the T cells and their cytokine production. Studies on the... -
- CITED
-
- Close
- SHARE
-
- Close
- Correlation of HLA-Cw6 Positivity with Clinical Characteristics and Treatment Efficacy in Korean Patients with Psoriasis
-
Kim SM, Lee H, Lee ES
- KMID: 2531872
- Ann Dermatol.
- 2022 Aug;34(4):253-260.
- doi: 10.5021/ad.21.100
Background: Psoriasis is a multifactorial, chronic immunological disease, in which a specific allele HLA-Cw6 is associated with various clinical manifestations. However, information regarding this genetic factor in Korean patients with... -
- CITED
-
- Close
- SHARE
-
- Close
- Quantification of Efflorescences in Pustular Psoriasis Using Deep Learning
-
Amruthalingam L, Buerzle O, Gottfrois P, Jimenez AG, Roth A, Koller T, Pouly M, Navarini AA
- KMID: 2532449
- Healthc Inform Res.
- 2022 Jul;28(3):222-230.
- doi: 10.4258/hir.2022.28.3.222
Objectives: Pustular psoriasis (PP) is one of the most severe and chronic skin conditions. Its treatment is difficult, and measurements of its severity are highly dependent on clinicians’ experience. Pustules... -
- CITED
-
- Close
- SHARE
-
- Close
